Lion Point Capital, LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Lion Point Capital, LP disclosed 19 US equity positions worth $19.1m in its Q4 2024 13F filing. The largest position was INSM at 13.3% of the reported book, followed by MIST and GERN. Against the Q3 2024 filing, it opened 1 new position, added to 4 and reduced 8 among the top 19 holdings.
What did Lion Point Capital, LP own in Q4 2024? Top 19 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | INSM INSMED INC | Healthcare | 13.3% | $2.5m | 36,700 | -30% | reduced |
| 2 | MIST MILESTONE PHARMACEUTICALS IN | 12.7% | $2.4m | 1,025,806 | -38% | reduced | |
| 3 | GERN GERON CORP | Healthcare | 9.3% | $1.8m | 500,000 | -21% | reduced |
| 4 | ARDX ARDELYX INC | Healthcare | 8.9% | $1.7m | 335,400 | -9% | reduced |
| 5 | FENC FENNEC PHARMACEUTICALS INC | 6.5% | $1.2m | 195,700 | -9% | reduced | |
| 6 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 5.8% | $1.1m | 40,300 | -18% | reduced |
| 7 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 5.1% | $972.5k | 79,000 | 0% | held |
| 8 | KINIKSA PHARMACEUTICALS LTD | 4.8% | $907.9k | 45,900 | -25% | reduced | |
| 9 | BHVN BIOHAVEN LTD | Healthcare | 4.4% | $847.8k | 22,700 | -36% | reduced |
| 10 | BENITEC BIOPHARMA INC | 4.1% | $783.1k | 62,000 | 59% | added | |
| 11 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.8% | $727.1k | 55,000 | 19% | added |
| 12 | JSPR JASPER THERAPEUTICS INC | 3.6% | $684.2k | 32,000 | 0% | held | |
| 13 | AVADEL PHARMACEUTICALS PLC | 3.5% | $672.6k | 64,000 | 0% | held | |
| 14 | IRON DISC MEDICINE INC | Healthcare | 3.5% | $672.0k | 10,600 | 38% | added |
| 15 | BLUEBIRD BIO INC | 3.4% | $658.1k | 78,912 | – | new | |
| 16 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 3.4% | $645.0k | 46,300 | 32% | added |
| 17 | RGNX REGENXBIO INC | Healthcare | 2.3% | $446.4k | 57,750 | 0% | held |
| 18 | MCRB SERES THERAPEUTICS INC | Healthcare | 1.5% | $283.2k | 340,761 | 0% | held |
| 19 | SPRB SPRUCE BIOSCIENCES INC | 0.2% | $31.5k | 75,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.